januxrx.com (JANX) - Volume dana dhuwit perusahaan

Simbol resmi perusahaan Janux Therapeutics (JANX)

Janux Therapeutics (JANX) possesses colossal scientific and technical potential in creating innovative T-cell activators. The company's cash balance on the GURU.Markets chart confirms financial stability, where the 0.94 metric serves as the target level. Future therapy approval will ensure premium pricing power. Operational stability of the business is guaranteed by outsourcing clinical trials to external contractors and utilizing redundant laboratories.

JANX - Cadangan dhuwit perusahaan Janux Pharma ing rentang 04.07.2022 - 21.11.2026

Rincian analitis perusahaan Janux Therapeutics

- rega saiki lan proyeksi nilai saham:
Pambiji fundamental perusahaan:Janux Therapeutics Inc JANX
Produk merek Janux Therapeutics, Inc.

This indicator reflects the liquid cash balances in settlement accounts, allowing for an assessment of the issuer's ability to cover current expenses without incurring debt. By analyzing the cash volume trend, an investor can see the financial cushion of Janux Therapeutics (JANX), which is critical for funding immunotherapy development until payments are received from pharma behemoths or insurance companies for cancer drugs.

Pesaing Janux Therapeutics (JANX)

Dhuwit awis perusahaan IBRX (ImmunityBio Corp)|Gunggung dana dhuwit perusahaan IMCR|Volume dana dhuwit perusahaan RCUS (Arcus Biosciences)|Sisa dhuwit perusahaan ZYME|tangotx.com - Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan Iovance Corp|Immatics N.V. (IMTX) - Dana dhuwit perusahaan|Xencor, Inc. - Sisa dhuwit perusahaan|CMPX (compasstherapeutics.com) - Volume dana dhuwit perusahaan|Volume dana dhuwit perusahaan Replimune Group Inc|Dana dhuwit perusahaan Lyell Immunopharma, Inc. (LYEL)|IPHA: Total volume dana dhuwit perusahaan|Pyxis Oncology - Dhuwit awis perusahaan|Compugen Limited (CGEN) - Cadangan dhuwit perusahaan|IO Biotech Inc - Volume dana dhuwit perusahaan|Aset likuid perusahaan Sutro Bio STRO|INKT: Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan Werewolf (HOWL)|Dana dhuwit perusahaan immixbio.com|Dhuwit awis lan setara dhuwit awis perusahaan ALXO (ALX Oncology)|Volume dana dhuwit perusahaan CUE|PDSB (PDS Biotechnology Corporation) - Sisa dhuwit perusahaan|Volume dana dhuwit perusahaan SONN (Sonnet BioTherapeutics Holdings)|Sisa dhuwit perusahaan MAIA|Liminatus - Volume dana dhuwit perusahaan|lavatherapeutics.com - Gunggung dana dhuwit perusahaan|NextCure (NXTC) - Dana dhuwit perusahaan|Leap Therapeutics Inc - Sisa dhuwit perusahaan|Dhuwit awis perusahaan INTS|Dana dhuwit perusahaan SNSE|Volume dana dhuwit perusahaan TOVX|GRTS - Cadangan dhuwit perusahaan|Dana dhuwit perusahaan kinetabio.com KA|Sisa dhuwit perusahaan NEXI|turnstonebio.com - Volume dana dhuwit perusahaan|VCNX (Vaccinex, Inc) - Dhuwit awis lan setara dhuwit awis perusahaan|Harpoon Therapeutics (HARP) - Dana dhuwit perusahaan